First Trust Advisors
IMI

First Trust Advisors’s Intermolecular, Inc. IMI Stock Holding History

First Trust Advisors’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-19,733
Closed -$143K – 2343
2013
Q2 		$143K Buy
+19,733
New +$168K ﹤0.01% 2184

Other funds holding IMI

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Trust Advisors's IMI Position: Q3 2013 in Review

First Trust Advisors sold out of Intermolecular, Inc. (IMI) in Q3 2013, closing a stake of 19,733 shares — an estimated $143K sold.

First Trust Advisors first reported a position in IMI in Q2 2013 and held it in 1 quarter. The position peaked at $143K in Q2 2013. 62 funds tracked by Wall St. Rank hold IMI as of Q3 2013.

  • First Trust Advisors reported no remaining Intermolecular, Inc. position as of Q3 2013 after selling out during the quarter.
  • First Trust Advisors sold 19,733 Intermolecular, Inc. shares in Q3 2013, an estimated $143K.
  • First Trust Advisors first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 1 quarter.
  • First Trust Advisors's Intermolecular, Inc. position peaked at $143K in Q2 2013.
  • 62 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2013.

Based on First Trust Advisors's 13F filing for Q3 2013, filed 12 Nov 2013.